Micropaque

Barium sulfate, the active ingredient in Micropaque, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque contrast to enhance X‑ray imaging of the gastrointestinal tract in patients undergoing diagnostic radiology procedures.

GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque is used as a radiopaque contrast agent for gastrointestinal imaging procedures.

- Upper gastrointestinal tract (barium swallow): enhances visualization of the esophagus, stomach and duodenum for diagnostic assessment. - Lower gastrointestinal tract (barium enema): provides contrast for colon and rectum evaluation. - Small‑bowel follow‑through: delineates the small intestine to detect lesions, strictures or malabsorption.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal cramping: intermittent discomfort during or after the study. - Constipation: reduced bowel movements for a short period. - Metallic taste: transient alteration of oral sensation.

Serious or Rare Side Effects: - Allergic reaction: includes rash, itching or anaphylaxis. - Aspiration pneumonia: risk if the suspension enters the airway. - Bowel perforation: severe pain indicating possible injury. - Rectal bleeding: unexpected bleeding after a barium enema.

When using Micropaque, clinicians should observe several safety measures.

- Assess bowel integrity: ensure no known obstruction or perforation before administration. - Review patient history: identify prior reactions to barium or other contrast agents. - Hydration: encourage adequate fluid intake after the procedure to aid elimination. - Pregnancy considerations: use only if the diagnostic benefit outweighs potential risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Micropaque can interact with other agents that affect imaging quality or patient safety.

Major Interactions (Avoid): - Potassium iodide preparations: may interfere with radiographic interpretation. - High‑dose antacids containing aluminum or magnesium: can alter suspension consistency. - Radiopharmaceuticals: may affect the accuracy of concurrent nuclear imaging studies.

Moderate Interactions (Monitor Closely): - Diuretics: monitor fluid balance to prevent dehydration. - Laxatives: may increase barium transit and affect image quality.